Cargando…
Combination of anlotinib and gemcitabine promotes the G0/G1 cell cycle arrest and apoptosis of intrahepatic cholangiocarcinoma in vitro
BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is a malignant carcinoma with high rate of mortality. The current treatment is ineffective with poor survival time. Therefore, there is an urgent need for effective therapeutic drug regimens. The multi‐target tyrosine kinase inhibitor (TKI) anlotinib...
Autores principales: | Fan, Shanshan, Ge, Yang, Liu, Jian, Liu, Heshu, Yan, Rui, Gao, Tianbo, Fan, Xiaona, Xiao, Zeru, An, Guangyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529129/ https://www.ncbi.nlm.nih.gov/pubmed/34462984 http://dx.doi.org/10.1002/jcla.23986 |
Ejemplares similares
-
Advanced intrahepatic cholangiocarcinoma treated using anlotinib and microwave ablation: A case report
por: Zhang, Aixia, et al.
Publicado: (2019) -
Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma
por: Song, Fei, et al.
Publicado: (2020) -
Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma
por: Ge, Yang, et al.
Publicado: (2022) -
Anlotinib Suppressed Ovarian Cancer Progression via Inducing G2/M Phase Arrest and Apoptosis
por: Zhu, Yanghui, et al.
Publicado: (2022) -
Tectorigenin Inhibits Glioblastoma Proliferation by G0/G1 Cell Cycle Arrest
por: Yeh, Liang-Tsai, et al.
Publicado: (2020)